Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Combination Cetuximab-Chemotherapy Regimen Shows Survival Benefit in Patients with Advanced NSCLC
Link ID 6379
Title Combination Cetuximab-Chemotherapy Regimen Shows Survival Benefit in Patients with Advanced NSCLC
Url http://www.medscape.com/viewarticle/575428?src=rss
Description Cetuximab combined with cisplatin/vinorelbine showed a small overall survival benefit in patients with advanced non-small-cell lung cancer over chemotherapy alone. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Jun 6, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. In Atypical Ductal Hyperplasia, Absence of Cytokeratin 5 Expression Is Ominous
  Cytokeratin 5 (CK5) expression in breast tissue indicates ductal carcinoma in situ, even if the patient presents with atypical ductal hyperplasia; the presence of CK5 is a good prognosticator. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Debate: Paclitaxel Plus Carboplatin as Systemic Therapy for Endometrial Cancers
  Two opposing sides of the story of the best regimen for recurrent and metastatic endometrial cancer are told. Clinical Ovarian Cancer
Category:   Articles > Hematology-Oncology


3. EGFR Possible Therapeutic Target in Triple-Negative Breast Cancer
  Although the study did not reach its primary endpoint, researchers say that EGFR should continue to be investigated as a potential therapeutic target. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Cord Blood Stem Cell Transplant Linked to Colitis Syndrome Cord Blood Stem Cell Transplant Linked to
  Cord colitis syndrome is different from acute graft-vs-host disease and other causes of diarrhea in patients who have undergone cord blood stem cell transplantation. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. If I Were Head of ASCO
  Dr. John Marshall proposes restructuring ASCO so that the primary presentation of new data occurs at smaller meetings and a synthesis of what has been learned over the year occurs at "big" ASCO. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS